Current Protein Identity:P0A6M2 New Search
Main Difference Dimensions in This Set
Different construct Different mutation/modification Different assembly state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics

Difference tags compare only the current result set; every original PDB and assembly record remains separate.

Related-Structure Differences

Each row represents one biological assembly in one PDB entry; multiple monomers of the same protein are listed separately.

PDB Entry Assembly / Oligomeric State Construct Mutations and Modifications Ligands, Ions and Non-polymers Experimental Method Experimental Conditions Structure Quality
2HI7 Crystal structure of DsbA-DsbB-ubiquinone complex Deposited 2006-06-29 Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain B 1–176(176 aa)
Mutation:C8A,C49V,C130S ZN ZINC ION × 1 UQ1 UBIQUINONE-1 × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 7;293 K;JeffamimeED2001, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K
Resolution 3.70 Å R-free 0.362
2HI7 Crystal structure of DsbA-DsbB-ubiquinone complex Deposited 2006-06-29 Assembly 2 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain B 1–176(176 aa)
Mutation:C8A,C49V,C130S ZN ZINC ION × 2 UQ1 UBIQUINONE-1 × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 7;293 K;JeffamimeED2001, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K
Resolution 3.70 Å R-free 0.362
2K73 Solution NMR structure of integral membrane protein DsbB Deposited 2008-08-01 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1–176(176 aa)
Mutation:C8A, C44S, C49A, C104S No recorded non-water small molecule SOLUTION NMR
NMR measurement conditions pH 6.2;313 K;Ionic strength (raw mmCIF value) 0.1;Pressure ambient
NMR sample composition 1.2 mM [U-13C; U-15N; U-2H] DsbB[CSSC], 100 mM [U-2H] DPC, 25 mM sodium phosphate, 50 mM potassium chloride, 95% H2O/5% D2O | 95% H2O/5% D2O
NMR sample composition 1.5 mM I,L,V methyl protonated, [U-13C; U-15N; U-2H] DsbB[CSSC], 100 mM [U-2H] DPC, 25 mM sodium phosphate, 50 mM potassium chloride, 95% H2O/5% D2O | 95% H2O/5% D2O
NMR sample composition 0.75 mM [U-15N; U-2H] DsbB[CSSC] single Cys mutants, 100 mM DPC, 25 mM sodium phosphate, 50 mM potassium chloride, 95% H2O/5% D2O | 95% H2O/5% D2O
Resolution not provided
2K74 Solution NMR structure of DsbB-ubiquinone complex Deposited 2008-08-01 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1–176(176 aa)
Mutation:C8A, C44S, C49A, C104S UQ2 UBIQUINONE-2 × 1 SOLUTION NMR
NMR measurement conditions pH 6.2;313 K;Ionic strength (raw mmCIF value) 0.1;Pressure ambient
NMR sample composition 1.2 mM [U-13C; U-15N; U-2H] DsbB[CSSC], 100 mM [U-2H] DPC, 25 mM sodium phosphate, 50 mM potassium chloride, 95% H2O/5% D2O | 95% H2O/5% D2O
NMR sample composition 1.5 mM I,L,V methyl protonated, [U-13C; U-15N; U-2H] DsbB[CSSC], 100 mM [U-2H] DPC, 25 mM sodium phosphate, 50 mM potassium chloride, 95% H2O/5% D2O | 95% H2O/5% D2O
NMR sample composition 0.75 mM [U-15N; U-2H] DsbB[CSSC] single Cys mutants, 100 mM DPC, 25 mM sodium phosphate, 50 mM potassium chloride, 95% H2O/5% D2O | 95% H2O/5% D2O
NMR sample composition 0.4 mM [U-13C; U-15N; U-2H] DsbB[CSSC], 2.0 mM UQ2, 5 % [U-2H] DMSO, 25 mM sodium phosphate, 50 mM potassium chloride, 100 mM [U-2H] DPC, 100% D2O | 100% D2O
NMR sample composition 0.4 mM [U-13C; U-15N; U-2H] DsbB[CSSC], 2.0 mM UQ2, 5 % [U-2H] DMSO, 25 mM sodium phosphate, 50 mM potassium chloride, 100 mM [U-2H] DPC, 95% H2O/5% D2O | 95% H2O/5% D2O
NMR sample composition 10 uM [U-15N; U-2H] DsbB[CSSC] L30C-MTSL/dMTSL, 0.6 mM UQ2, 5 % [U-2H] DMSO, 25 mM sodium phosphate, 50 mM potassium chloride, 100 mM [U-2H] DPC, 100% D2O | 100% D2O
Resolution not provided
2LEG Membrane protein complex DsbB-DsbA structure by joint calculations with solid-state NMR and X-ray experimental data Deposited 2011-06-15 Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain B 1–176(176 aa)
Mutation:C8A, C49V, C130S ZN ZINC ION × 1 UQ1 UBIQUINONE-1 × 1 SOLID-STATE NMR
NMR measurement conditions pH 7;270 K;Pressure ambient
NMR measurement conditions pH 7.8;261 K;Pressure ambient
NMR sample composition 15 mg [U-100% 13C; U-100% 15N] DsbA, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition 10 mg [2-13C-glycerol; U-15N] DsbA, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition 10 mg [1,3-13C-glycerol; U-15N] DsbA, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition 7 mg [U-100% 13C; U-100% 15N] DsbB, 2 mg DDM, 7 mg E. coli lipids, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition 5 mg [2-13C-glycerol; U-15N] DsbB, 2 mg DDM, 7 mg E. coli lipids, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition 4 mg [1,3-13C-glycerol; U-15N] DsbB, 2 mg DDM, 7 mg E. coli lipids, 90% H2O/10% D2O | 90% H2O/10% D2O
Resolution not provided
2LTQ High resolution structure of DsbB C41S by joint calculation with solid-state NMR and X-ray data Deposited 2012-05-30 Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain A 1–176(176 aa)
Mutation:C8A,C41S,C49V UQ8 Ubiquinone-8 × 1 SOLID-STATE NMR
NMR measurement conditions pH 7.8;261 K;Pressure ambient
NMR sample composition 7 mg [U-100% 13C; U-100% 15N] DsbB, 2 mg DDM, 7 mg E. coli lipids, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition 5 mg [2-13C-glycerol; U-15N] DsbB, 2 mg DDM, 7 mg E. coli lipids, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition 4 mg [1,3-13C-glycerol; U-15N] DsbB, 2 mg DDM, 7 mg E. coli lipids, 90% H2O/10% D2O | 90% H2O/10% D2O
Resolution not provided
2LTQ High resolution structure of DsbB C41S by joint calculation with solid-state NMR and X-ray data Deposited 2012-05-30 Assembly 2 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain D 1–176(176 aa)
Mutation:C8A,C41S,C49V UQ8 Ubiquinone-8 × 1 SOLID-STATE NMR
NMR measurement conditions pH 7.8;261 K;Pressure ambient
NMR sample composition 7 mg [U-100% 13C; U-100% 15N] DsbB, 2 mg DDM, 7 mg E. coli lipids, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition 5 mg [2-13C-glycerol; U-15N] DsbB, 2 mg DDM, 7 mg E. coli lipids, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition 4 mg [1,3-13C-glycerol; U-15N] DsbB, 2 mg DDM, 7 mg E. coli lipids, 90% H2O/10% D2O | 90% H2O/10% D2O
Resolution not provided
2ZUP Updated crystal structure of DsbB-DsbA complex from E. coli Deposited 2008-10-28 Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain B 1–176(176 aa)
Mutation:C8A,C49V,C130S ZN ZINC ION × 1 UQ1 UBIQUINONE-1 × 1 X-RAY DIFFRACTION
X-ray crystallization conditions EVAPORATION;pH 7;293 K;23% Jeffamine ED2001, 80mM HEPES, 14.4% glycerol, 2mM ZnCl2, pH 7.0, EVAPORATION, temperature 293K
Resolution 3.70 Å R-free 0.334
2ZUQ Crystal structure of DsbB-Fab complex Deposited 2008-10-28 Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain A 1–176(176 aa)
Mutation:C8A,C41S,C49V UQ1 UBIQUINONE-1 × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;pH 7;293 K;15% PEG3350, pH 7, VAPOR DIFFUSION, temperature 293K
Resolution 3.30 Å R-free 0.351
2ZUQ Crystal structure of DsbB-Fab complex Deposited 2008-10-28 Assembly 2 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain D 1–176(176 aa)
Mutation:C8A,C41S,C49V UQ1 UBIQUINONE-1 × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;pH 7;293 K;15% PEG3350, pH 7, VAPOR DIFFUSION, temperature 293K
Resolution 3.30 Å R-free 0.351
3E9J Structure of the charge-transfer intermediate of the transmembrane redox catalyst DsbB Deposited 2008-08-22 Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 1–176(176 aa)
Mutation:C8A, C49V UQ1 UBIQUINONE-1 × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 8.9;277 K;23% PEG550 MME, 50 mM Tris pH 8.9, 1.0 M ammonium formate, VAPOR DIFFUSION, SITTING DROP, temperature 277K
Resolution 3.70 Å R-free 0.379
3E9J Structure of the charge-transfer intermediate of the transmembrane redox catalyst DsbB Deposited 2008-08-22 Assembly 2 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain F 1–176(176 aa)
Mutation:C8A, C49V UQ1 UBIQUINONE-1 × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 8.9;277 K;23% PEG550 MME, 50 mM Tris pH 8.9, 1.0 M ammonium formate, VAPOR DIFFUSION, SITTING DROP, temperature 277K
Resolution 3.70 Å R-free 0.379
6WVF E.coli DsbB C104S with ubiquinone Deposited 2020-05-05 Assembly 1 Insufficient information Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 6–167(162 aa)
Mutation:C8A,C49V,C104S Non-standard monomer:Yes (specific site not provided by mmCIF) UQ1 UBIQUINONE-1 × 1 X-RAY DIFFRACTION
X-ray crystallization conditions LIPIDIC CUBIC PHASE;295 K;34% PEG 400, 60 mM NaCl, 0.1 M HEPES pH 7.5
Resolution 2.90 Å R-free 0.286